Marijuana for HIV-Related Peripheral Neuropathy

Completed · Phase 1/Phase 2

Conditions studied: Peripheral Nervous System Diseases, HIV Infections

In brief

To evaluate whether smoked marijuana reduces pain in people with HIV-related peripheral neuropathy.

Key facts

Study ID

NCT00046722

Run by

Center for Medicinal Cannabis Research

People needed

50

Starts

2003-01-01

Expected to finish

2005-04-01

Last updated by the study team

2007-06-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• HIV positive.
• Be 18 years or older.
• Diagnosis of HIV-related painful neuropathy.
• Stable antiretroviral therapy or no antiretroviral therapy for at least 8 weeks.
• Prior use of marijuana, at least 6 occasions in their lifetime prior to enrollment.
• EXCLUSION CRITERIA: (Not allowed)
• Current use of smoked tobacco products.
• Current methadone treatment.
• Use of smoked marijuana within 30 days of enrollment.
• Diagnosis of diabetes mellitus.
• Currently receiving treatment with corticosteroids.
• Use of INH, dapsone or metronidazole within 8 weeks prior to enrollment.
• Severe heart disease, uncontrolled high blood pressure or lung disease.
• Women who are pregnant or breastfeeding.

Where it is running

• University of California, San Francisco Community Consortium — San Francisco, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.